|
PRPF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.804800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.442280E-03 |
| Normal-vs-Stage2 |
2.193800E-01 |
| Normal-vs-Stage3 |
9.175800E-01 |
| Normal-vs-Stage4 |
9.284000E-01 |
| Stage1-vs-Stage2 |
5.004800E-01 |
| Stage1-vs-Stage3 |
5.529600E-02 |
| Stage1-vs-Stage4 |
2.156800E-01 |
| Stage2-vs-Stage3 |
3.123000E-01 |
| Stage2-vs-Stage4 |
3.749400E-01 |
| Stage3-vs-Stage4 |
9.917600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.815300E-03 |
| Normal-vs-AfricanAmerican |
9.522100E-03 |
| Normal-vs-Asian |
4.182800E-01 |
| Caucasian-vs-AfricanAmerican |
7.290800E-01 |
| Caucasian-vs-Asian |
7.763200E-01 |
| AfricanAmerican-vs-Asian |
8.181600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.780100E-03 |
| Normal-vs-Female |
6.879900E-02 |
| Male-vs-Female |
6.022200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.642400E-03 |
| Normal-vs-Extreme_Weight |
5.644200E-04 |
| Normal-vs-Obese |
6.787400E-01 |
| Normal-vs-Extreme_Obese |
3.884300E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.006800E-01 |
| Normal_Weight-vs-Obese |
8.056100E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.679800E-01 |
| Extreme_Weight-vs-Obese |
9.088500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.581200E-01 |
| Obese-vs-Extreme_Obese |
8.711600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.088200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.666400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.022800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.324500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.495000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.473400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.015200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.823610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.015800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.655400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.557100E-03 |
| Normal-VS-Type2 PRCC |
3.488000E-01 |
| Normal-VS-KIRP CIMP |
9.902800E-01 |
| Normal-VS-Unclassified PRCC |
2.143600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.583200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.190000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.290400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.941200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.140200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.016000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.641540E-02 |
| Normal-vs-N1 |
7.554000E-01 |
| Normal-vs-N2 |
1.872050E-02 |
| N0-vs-N1 |
6.103600E-02 |
| N0-vs-N2 |
5.530200E-01 |
| N1-vs-N2 |
1.925980E-01 |
|
|
